Seaport Therapeutics, Inc.
SPTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002042347
In the last 90 days, Seaport Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 73 institutions reported holding it in 13F filings for Q3 2026, worth $766.9M in total; no superinvestor holds it.
Holders of 5% or more of SPTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Seaport Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| PureTech LYT, Inc. | 13G | 31.20%16.7M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| ARCH Venture Fund XII, L.P. | 13D | 11.90%6.29M shares | New | May 6, 20261 filing | May 6, 2026 | SEC |
| General Atlantic LLC | 13D | 11.50%6.10M shares | New | May 11, 20261 filing | May 11, 2026 | SEC |
| Zohar Daphne | 13G | 9.10%5.23M shares | New | Aug 5, 20261 filing | Aug 5, 2026 | SEC |
| Paul Steven M | 13G | 6.30%3.52M shares | New | Aug 5, 20261 filing | Aug 5, 2026 | SEC |
| Goldman Sachs Group Inc | 13G | 5.50%2.79M shares | New | May 11, 20261 filing | May 11, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Seaport Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:30 PM ET | PureTech LYT, Inc.and 2 others | 13G | 31.20%16.7M shares | New | Jun 30, 2026 | SEC |
| Aug 5, 20268:06 AM ET | Zohar Daphne | 13G | 9.10%5.23M shares | New | Jun 30, 2026 | SEC |
| Aug 5, 20266:01 AM ET | Paul Steven M | 13G | 6.30%3.52M shares | New | Jun 30, 2026 | SEC |
| May 11, 20267:54 PM ET | General Atlantic LLCand 13 others | 13D | 11.50%6.10M shares | New | May 4, 2026 | SEC |
| May 11, 20263:19 PM ET | Goldman Sachs Group Incand 1 other | 13G | 5.50%2.79M shares | New | May 6, 2026 | SEC |
| May 6, 20264:26 PM ET | ARCH Venture Fund XII, L.P.and 6 others | 13D | 11.90%6.29M shares | New | May 4, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Seaport Therapeutics, Inc. shares.
No Form 144 notices for Seaport Therapeutics, Inc. are on file.